鲁抗医药：拟以自有资金对两家全资子公司增资

Group 1 - The core point of the article is that LuKang Pharmaceutical plans to increase the registered capital of its wholly-owned subsidiaries, aiming to strengthen its agricultural pesticide and sales sectors to meet business expansion needs [1] - LuKang Pharmaceutical will increase the registered capital of Shandong LuKang Biological Pesticide Co., Ltd. from 41.25 million yuan to 150 million yuan, and Shandong LuKang Zerun Pharmaceutical Co., Ltd. from 3 million yuan to 30 million yuan [1] - The revenue composition for LuKang Pharmaceutical in 2024 is projected to be 54.29% from human antibiotics, 39.72% from veterinary antibiotics, 4.89% from other sources, and 1.1% from other businesses [1] - As of the report date, LuKang Pharmaceutical has a market capitalization of 8.4 billion yuan [1]